EARLY TESTING PRECLINICAL DEVELOPMENT CLINICAL TRIALS CONTACT ABOUT IRIS PHARMA IRIS PHARMA’S RESPONSE TO COVID-19 PANDEMIC La Gaude - France, September, 15th 2020 Dear Customers, Despite the COVID-19 pandemic and as events continue in different countries, Iris Pharma would like to reassure its clients. From the beginning, Iris Pharma remains fully operational and continues to meet its clients’ needs for planned and new R&D Ophthalmology projects. The risk of infection remains present, and, being fully compliant with COVID-19 health authorities and French government guidelines, we have taken the following measures in order to protect our employees: • Physical distancing practices • Daily cleaning of common touch points (doorknobs, break areas, etc.) • Reminders of good hygiene practices • Face coverings for employees and visitors according to applicable government guidance • Part-time remote working for eligible employees to minimize the number of people on site • Employee self-monitoring for illness symptoms • Strict visitor policies • Restrictions on all non-essential business travel • Our global Business Continuity Plans is active Please feel free to contact us for any question or concern. We thank you for your cooperation and for using the services of Iris Pharma. #TogetherAgainstCovid19 – Stay Safe Yann Quentric, M.Sc. President, Iris Pharma Holding SAS ▶ Iris Pharma – Allée Hector Pintus – 06610 La Gaude – France Tel +33 493 594 959 – Fax +33 493 594 950 www.iris-pharma.com #TogetherAgainstCovid19 – Stay Safe Have questions or need help with your ophthalmology development programs ? Ask Our Experts Iris Pharma A leading contract research organization (CRO) dedicated to ophthalmic research, Iris Pharma partners with clients to carry out preclinical research and clinical studies involving all areas of the field, from the ocular surface to the posterior segment of the eye. View More Preclinical development In vivo Pharmacology Studies GLP Ocular Tolerance & Safety GLP Ocular Pharmacokinetics Equipment Early testing Efficacy & Proof of Concept Early Pharmacokinetics Pilot Tolerance & Safety Testing Formulation & Delivery Clinical Trials Clinical Trial Services Ophthalmic Indications Clinical Trial Phases Countries About Iris Pharma Who We Are Services Ocular Expertise Publications News & Media Events Legal notice - Sitemap - Contact us Copyright 2021 - Iris Pharma - ckc-net.com This website intends to use cookies to improve the site and your experience. By continuing to browse the site you are agreeing to accept our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, visit Use of cookies Accept cookiesRefuse cookies